Patrick Wood
Stock Analyst at Morgan Stanley
(3.05)
# 1,229
Out of 4,884 analysts
89
Total ratings
45.45%
Success rate
2.05%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Maintains: Equal-Weight | $240 → $260 | $237.55 | +9.45% | 4 | May 19, 2025 | |
| BSX Boston Scientific | Maintains: Overweight | $120 → $125 | $104.32 | +19.82% | 6 | May 16, 2025 | |
| GKOS Glaukos | Maintains: Underweight | $110 → $72 | $103.50 | -30.43% | 4 | May 6, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $86 → $78 | $76.07 | +2.54% | 6 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $280 → $196 | $176.16 | +11.26% | 4 | May 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $12 | $13.88 | -13.54% | 7 | May 6, 2025 | |
| TFX Teleflex | Maintains: Overweight | $191 → $173 | $119.90 | +44.29% | 5 | May 5, 2025 | |
| BAX Baxter International | Maintains: Underweight | $30 → $28 | $31.01 | -9.71% | 4 | May 5, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $80 | $78.50 | +1.91% | 4 | Mar 5, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Equal-Weight | $45 → $22 | $16.78 | +31.11% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $105 → $95 | $57.92 | +64.02% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $82 | $82.93 | -1.12% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $75 | $76.79 | -2.33% | 8 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $73.30 | +39.15% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $301.05 | +5.30% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $7.61 | +31.41% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $145 | $129.19 | +12.24% | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $65 → $85 | $87.83 | -3.22% | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $17.95 | +106.13% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $36 | $13.05 | +175.86% | 1 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $142.56 | - | 5 | Dec 11, 2017 |
STERIS
May 19, 2025
Maintains: Equal-Weight
Price Target: $240 → $260
Current: $237.55
Upside: +9.45%
Boston Scientific
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $104.32
Upside: +19.82%
Glaukos
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $103.50
Upside: -30.43%
GE HealthCare Technologies
May 6, 2025
Maintains: Equal-Weight
Price Target: $86 → $78
Current: $76.07
Upside: +2.54%
Becton, Dickinson and Company
May 6, 2025
Maintains: Overweight
Price Target: $280 → $196
Current: $176.16
Upside: +11.26%
Bausch + Lomb
May 6, 2025
Maintains: Equal-Weight
Price Target: $18 → $12
Current: $13.88
Upside: -13.54%
Teleflex
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $119.90
Upside: +44.29%
Baxter International
May 5, 2025
Maintains: Underweight
Price Target: $30 → $28
Current: $31.01
Upside: -9.71%
Solventum
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $73 → $80
Current: $78.50
Upside: +1.91%
Tandem Diabetes Care
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $16.78
Upside: +31.11%
Feb 26, 2025
Maintains: Overweight
Price Target: $105 → $95
Current: $57.92
Upside: +64.02%
Feb 14, 2025
Maintains: Equal-Weight
Price Target: $75 → $82
Current: $82.93
Upside: -1.12%
Feb 12, 2025
Maintains: Equal-Weight
Price Target: $70 → $75
Current: $76.79
Upside: -2.33%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $73.30
Upside: +39.15%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $301.05
Upside: +5.30%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $7.61
Upside: +31.41%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $104 → $145
Current: $129.19
Upside: +12.24%
Jul 15, 2024
Upgrades: Equal-Weight
Price Target: $65 → $85
Current: $87.83
Upside: -3.22%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $17.95
Upside: +106.13%
Dec 4, 2023
Initiates: Overweight
Price Target: $36
Current: $13.05
Upside: +175.86%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $142.56
Upside: -